Traditional colorectal cancer (CRC) screening tools, such as carcinoembryonic antigen (CEA) and the fecal immunochemical test (FIT), focus primarily on tumor markers or occult gastrointestinal bleeding. The gene discussed is CEACAM5; the disease is colorectal cancer.